Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2014-09-29

FDA Approved: ACYCLOVIR — Supplemental Application (ACTAVIS PHARMA, INC.)

View source ↗

Summary

FDA approved a supplemental application for Acyclovir (Actavis Pharma) to update the labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ACYCLOVIR (Acyclovir)

Snippet

SUPPL AP for ACYCLOVIR (ACYCLOVIR)